PepGen Inc. (PEPG)

5.81 +0.47 (+8.80%) USD  |  NASDAQ  |  Dec 24, 12:59
5.81 0.00 (0.00%) After-Hours: 13:59
More

PepGen SG&A Expense (TTM): 22.10M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for PEPG.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Merck & Co., Inc. 10.70B
Sarepta Therapeutics, Inc. 527.29M
Gossamer Bio, Inc. 36.12M
Immuneering Corp. 16.50M
NovaBay Pharmaceuticals, Inc. 8.584M